John W. Longshore
John W. Longshore publishes mostly in Genetics, Molecular Biology and Pulmonary and Respiratory Medicine, on topics such as Genetics and Neurodevelopmental Disorders, Lung Cancer Treatments and Mutations and Cancer Genomics and Diagnostics.
- World rank
- #969,013 of 7,710,434 ranked researchers
- Rank in United States
- #317,524 of 1,627,098
- Works
- 62
- Citations
- 4.8k
- Citations per work
- 77.5
What does John W. Longshore research?
John W. Longshore's work is mostly in Biochemistry, Genetics and Molecular Biology (33%), Medicine (19%), Business, Management and Accounting (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else2743.7%
- Life Sciences2033.0%
- Health Sciences1218.8%
- Medicine1218.8%
- Social Sciences34.5%
- 1Genetics16% of their works
- 2Molecular Biology11% of their works
- 3Pulmonary and Respiratory Medicine10% of their works
- 4Oncology9% of their works
- 5Cancer Research6% of their works
- 6Management of Technology and Innovation4% of their works
Research topics
- Genetics and Neurodevelopmental Disorders
- Lung Cancer Treatments and Mutations
- Cancer Genomics and Diagnostics
- Quality Function Deployment in Product Design
- Cancer Immunotherapy and Biomarkers
- Genomic variations and chromosomal abnormalities
- Lung Cancer Research Studies
- Radiomics and Machine Learning in Medical Imaging
Which keywords describe John W. Longshore's research?
The keywords of their largest research topics: Targeted Therapy, Clinical Trials, Fragile X Syndrome, Rett Syndrome, ALK Inhibitors, EGFR Mutations, Cancer Genomics and Mutational Signatures.
- Small-Cell Lung Cancer
- Medical Imaging
- Genomic Profiles
- PD-1 and PD-L1
- Quality Function Deployment
- Mutational Signatures
- EGFR Mutations
- Rett Syndrome
- Clinical Trials
- Targeted Therapy
- Fragile X Syndrome
- ALK Inhibitors
- Cancer Genomics
- QFD
- Immune Checkpoint Blockade
- Copy Number Variation
- Genomic Rearrangements
- Radiomics
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Targeted Therapy213 topics
- Clinical Trials132 topics
- Fragile X Syndrome101 topic
- Rett Syndrome101 topic
- ALK Inhibitors91 topic
- EGFR Mutations91 topic
- Cancer Genomics81 topic
- Mutational Signatures81 topic
- QFD71 topic
- Quality Function Deployment71 topic
- Immune Checkpoint Blockade61 topic
- PD-1 and PD-L161 topic
- Copy Number Variation41 topic
- Genomic Profiles41 topic
- Genomic Rearrangements41 topic
- Medical Imaging41 topic
- Radiomics41 topic
- Small-Cell Lung Cancer41 topic
Where does John W. Longshore work?
John W. Longshore's main affiliation in the publication record is Greenwood Genetic Center, United States.
How many publications and citations does John W. Longshore have?
OpenAlex counts 62 works and 4,806 citations for John W. Longshore, an h-index of 21, ranking #969,013 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about John W. Longshore. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.